Bowling Portfolio Management LLC Regeneron Pharmaceuticals, Inc. Transaction History

Bowling Portfolio Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Jan 17, 2020	SELL	$274.13 - $376.51 $980,837 - $1.35 Million	-3,578 Closed	0 $0
Q3 2019 Oct 15, 2019	SELL	$273.46 - $318.39 $2.59 Million - $3.01 Million	-9,458 Reduced 72.55%	3,578 $993,000
Q2 2019 Jul 25, 2019	BUY	$299.6 - $414.82 $1.45 Million - $2.01 Million	4,849 Added 59.23%	13,036 $4.08 Million
Q1 2019 Apr 18, 2019	BUY	$372.08 - $439.57 $1.22 Million - $1.45 Million	3,291 Added 67.22%	8,187 $3.36 Million
Q4 2018 Jan 17, 2019	BUY	$335.82 - $403.04 $1.64 Million - $1.97 Million	4,896 New	4,896 $1.83 Million

1,429

82.1M

835K

1.46M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $113B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Bowling Portfolio Management LLC, based on Form 13F filings with the SEC.

Stay updated on Bowling Portfolio Management LLC with notifications on news.